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Background: The risk of low bone mineral density (BMD) occurs in adolescents
with cystic ﬁbrosis (CF). Some speciﬁc aspects like malnutrition, calcium, vita-
min D deﬁciency, frequent infections, physical inactivity and pubertal delay are the
risk factors in bone disease in CF.
Aim: Comparison of nutritional status, lung function and biochemical parameters
inﬂuencing bone mineralization in CF adolescents with normal and low BMD.
Methods: In 72 patients aged 9−18 years BMD Z-score in lumbar spine (L1−L4)
was measured. 31 patients with Z-score between −1 and −2 were classiﬁed as
“low BMD”, 41 with Z-score >−1 as a “normal BMD”. Anthropometric assessment,
vitamin D status, biochemical markers, urinary calcium excretion as well as lung
function were evaluated. Descriptive methods and Mann-Whitney test were used
for statistical analysis.
Results: Patients with low BMD had signiﬁcantly reduced standardized body weight
(−1.04±0.58 vs −0.38±0.90; p = 0.001) and height (−0.95±1.18 vs −0.14±1.10;
p = 0.002), as well as worse FEV1% (78.0±17.1 vs 87.7±18.9; p = 0.031). In both
groups mean serum vitamin 25(OH)D3 level was lower than 30 ng/ml and did not
differ. Mean serum calcium level, and its urinary excretion, PTH and creatinine
were within the normal range, except osteocalcin, which was increased in 93%
patients with low and in 82% with normal BMD, as well as ALP in 52% and 56%,
respectively. There were no signiﬁcant differences in above biochemical markers
between the groups.
Conclusion: CF adolescents with low BMD had poorer nutritional status and lung
function but similar biochemical markers like those with normal BMD.
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Objectives:We have shown that CF infants diagnosed via newborn screening (NBS)
and receiving high calorie and essential fatty acids were more likely to achieve
catch-up weight gain, recover their birth weight z-scores by 2 years (“responders”)
and maintain better growth through age 6 years. This study examined whether better
growth is sustained in adolescence.
Methods: CF children with pancreatic insufﬁciency, no meconium ileus, and
enrolled in the Wisconsin RCT of NBS were studied. Responders were considered
to maintain adequate growth if their height and BMI percentile at age 2 remained
within one growth channel on the 2000 CDC growth charts during age 2−6 and
6−12 years.
Conclusion: Of 53 patients followed to age 12, 36 (68%) were responders. Of
these, 27 (75%) maintained adequate growth at age 6, and 17 (47%) at age 12.
During age 12−18, responders showed signiﬁcantly better height (48th percentile)
and BMI (51th percentile) compared to non-responders (height 13th; BMI 34th).
Among responders, those with adequate growth at age 2−6 had signiﬁcantly better
adolescent BMI (60th) but similar height (49th) compared to those with declined
growth at age 2−6 (BMI 23rd; height 44th). Responders who maintained adequate
growth through age 12 (n = 17) had the best adolescent height (52nd) and BMI
(63th). Multiple regression analysis showed that NBS (p = 0.017) and responder
status at age 2 (p = 0.001) were associated with better adolescent height. These
data show that early diagnosis through NBS coupled to effective nutritional therapy
during the critical ﬁrst 2 years leads to better long term growth, especially during
adolescence.
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Objectives: Achievement of normal growth in infants is challenging, with positive
impact on pulmonary function later in life. We are conducting a 2-year French
survey, using data from physicians and dietitians; we present an interim analysis at
6 months.
Methods: Observational prospective study recruiting successive NBS infants with
classical CF (meconium ileus excluded). Collected information includes: weight
(W), length (L), BMI z scores (WHO growth charts), nutritional care, biological
and respiratory characteristics.
Results: The study included 106 infants from 30 CF centres (01/2010−08/2011).
For the 84 PI infants, at baseline and M6 (values expressed as median); W, L,
BMI z scores improved respectively from −2, −1.4, −1.2 to −1.2, −1.2, −0.7;
infant formula provided 129 and 117 %RDA calories, respectively; sodium (NA)
intake increased from 2 to 3.9meq/kg/d; enzyme substitution was 5517 and 5537 IU
lipase/kg/d; breastfeeding rate decreased from 47 to 20%; sputum was positive for
Pseudomonas aeruginosa (PA) in 5% at M6. For the 22 PS patients: W, L, BMI
z scores remained stable over time at −0.4, −0.9, −0.5 and −1.2, 0.2, −0.5; infant
formula provided identical 116% RDA calories; Na intake increased from 1.6 to 3.3
meq/kg/d; breastfeeding rate decreased from 30 to 20%; PA was positive in 5% and 2
infants became PI at M6. For both cohorts, the percentages of patients with anaemia,
hypoprotidaemia and low vitamin A, E and D levels decreased dramatically and Na
output in urine increased over time. We plan to present additional data comparing
feeding modalities, growth and pulmonary outcome so as to understand factors
interfering with optimal growth.
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Introduction: Cystic ﬁbrosis (CF) is characterized by chronic pulmonary disease
and poor nutrition. Optimal nutrition is associated with better pulmonary function
and increased survival. Therefore, nutritional body composition and especially lean
body mass must be closely monitored in CF patients. The gold standard method
by dual-energy X-ray absorptiometry (DEXA) is radiant and time consuming. A
routine pediatric clinical assessment of body composition is needed.
Objectives: The aim was to validate bioelectrical impedance as a routine measure
of the lean body-composition using a Bland-Altman statistical test.
Methods: All patients were assessed using bioelectrical impedance and dual-energy
X-ray absorptiometry (DEXA). In the mean time, anthropometric variables (weight,
height) were also measured between 2005 and 2012.
Results: 46 CF patients (29 males), median age 13 years, were included. The
intraclass correlation coefﬁcients comparing DEXA and biolelectrical impedance
were 0.991 for lean body mass weight, 0.954 for fat body mass weight and 0.99
for body weight.
Conclusion: Statistical analyses showed no differences between the two methods.
Bioelectrical impedance can be used as a routine pediatric clinical tool to follow-
up lean body mass index allowing a better nutritional evaluation and support in
CF patients.
